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Introduction
In adult mice, ovarian follicular development proceeds against a background of cyclical changes in the plasma concentrations of gonadotrophins, which are thought to control this process (Richards, 1980) . From a mathematical analysis of ovarian follicle dynamics in normal and in GnRH-deficient hypogonadal (hpg) mice we have suggested that gonadotrophins act at several stages during the development of ovarian follicles (Halpin et al, 1986a) , but these studies could not distinguish separate effects of FSH and LH. In fact, there is still considerable uncertainty over the separate roles of LH and FSH in the control of follicle development and in particular there is conflicting evidence about the roles of these hormones in the stimulation of development of antral follicles.
In hypogonadal mice endogenous FSH and LH are insufficient to stimulate preovulatory follicle development and the size of the growing follicle population is reduced (Halpin et al, 1986b) . These mice can therefore be used to study the effects of gonadotrophins on follicular development.
Materials and Methods
The mice used were hpg mutants or normal animals reared in the Department of Human Anatomy, Oxford, from an original stock provided by the MRC Radiobiology Unit, Harwell. Females were weaned at 18-20 days of age and maintained as described by Halpin et al (1986b) .
Three preparations of FSH with different biological activity and purity were used. NIH-oFSH-S13 is a preparation of sheep FSH kindly supplied by NIADDK, NIH, Bethesda, MD, U.S.A. It has a potency of 15 NIH-FSH-S1 units/mg (i.e. 15 i.u./mg) as determined by the hCG augmentation bioassay of Steelman & Pohley (1953) and an LH contamination of 005 NIH-LH-S1 units/mg as determined by the ovarian ascorbic acid-depletion bioassay (Parlow, 1961) . Its contamination with TSH, growth hormone and prolactin was less than 01% by weight (NIADDK Data Sheet). Another preparation of sheep FSH was also supplied by NIADDK; however, NIH-oFSH-S15 is more potent than S13 with an activity of 20 NIH-FSH-S1 units/mg (i.e. 20 i.u./mg) as determined by the hCG augmen¬ tation bioassay. It also contains slightly less LH than SI3 with a contamination of 004NIH-LH-S1 units/mg (ovarian ascorbic acid-depletion bioassay) and its contamination with TSH, growth hormone and prolactin was again <01% by weight (NIADDK Data Sheet (Reichert, 1967) . LER 8/116 has a potency of 35 NIH-FSH-S1 units/mg (i.e. 35 i.u./mg) as determined by the hCG augmentation bioassay, and it has an extremely low contami¬ nation with LH, estimated at 5-2 i.u./mg by the ventral prostate weight gain bioassay (Greep et al, 1942) equivalent to less than 001 NIH-LH-S1 units/mg (L. E. Reichert, personal communication) . Sheep LH, NIH-oLH-S24, again kindly supplied by NIADDK, was used for all the experiments involving LH. This has a potency of 2-3 NIH-LH-S1 units/mg as determined by the ovarian ascorbic acid-depletion bioassay, and contains <0-5% FSH by weight (NIADDK Data Sheet).
The hormone for injection was made up at the appropriate concentration in 0-9% (w/v) NaCl and injections were given subcutaneously in the nape of the neck. Groups oihpg females aged between 90 and 130 days were injected twice daily (at 10:00 and 22:00 h) for 4 or 5 days and vaginal smears were taken daily for each animal once vaginal opening had occurred. The morning after the last day of treatment, the animals were anaesthetized with 0-4 ml urethane solution (1 g ethyl carbamate/kg administered i.p. as a 10% solution in 0-9% NaCl). The ovaries were exposed via a flank incision, the ovarian blood vessels clamped and the ovaries removed and dissected free of surrounding fat. One ovary was fixed in 2% glutaraldehyde for ultrastructural studies and the other was fixed in Bouin's fluid for light microscopy. The uterus was also removed, dissected free of fat, fixed in Bouin's fluid and weighed after fixation.
The ovaries for light microscopy were embedded in paraffin wax and sectioned serially at 7 µ . The sections were stained with haematoxylin and eosin and for each animal the total number of follicles of each type was determined using the scheme of Pedersen & Peters (1968) as described previously (Halpin et al, 1986b 
Results

NIH-OFSH-S13
The effects upon the ovarian follicle population of twice daily injections of various doses of NIH-0FSH-SI3 for 4 days are shown in Table 1 . The dose of 600 ng had no significant effect upon (mg)
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the follicle population, whereas although there were no significant changes in the number of medium-sized follicles, 1 pg increased the number of type 3b follicles and resulted in the formation of type 7 antral follicles, which are never seen in the ovaries of untreated hpg mice. The effects of 3 pg were similar, but there was clear stimulation of antral follicle development. There was no significant difference between the number of type 3b follicles produced by injection of 1, 3 or 6 pg FSH-S13, but 12 pg produced a significantly greater increase in the number of type 3b follicles compared with any other treatment with FSH-S13 (P < 005). None of the treatments with NIH-0FSH-SI3 resulted in significant changes in the medium-sized follicle population and none of the treatments produced corpora lutea. However, the incidence of atretic large follicles was increased in animals injected with doses greater than 1 pg. The vagina of 4 out of 6 animals injected with 3 pg FSH had opened and showed a pro-oestrous smear at the end of the treatment period. Vaginal opening occurred in all the animals injected with 6 or 12 pg, and in all cases the smear was pro-oestrous at the time of killing. The uterine weights of these animals are also shown in Table 1 .
NIH-0FSH-SI5
The effects upon the ovarian follicle population of twice daily injections of NIH-oFSH-S15 are shown in Table 2 . The injection period was increased to 5 days because it was felt that this might produce a more consistent response within each group. Doses of 600 ng and 1 pg had no significant effect upon the follicle population, whilst doses of 2 pg and above increased both the number of early growing follicles and stimulated antral follicle formation. The numbers of type 3b and type 8 follicles produced by injection of FSH-S15 were not significantly different from the numbers produced by FSH-S13.
The uterine weights in these animals (Table 2) were similar to those in animals injected with FSH-S13. Doses greater than 2 pg produced significant increases in the uterine weight and the higher doses of 3, 6 and 12 pg resulted in a uterine weight which was significantly greater than that produced by 2µg(P < 001).
The effects upon the ovary of 3 pg FSH-S15 were further characterized by an ultrastructural study. This dose was chosen for more detailed studies as it was the lowest effective dose which produced an increase in the size of the growing follicle pool, healthy ripe follicles and significant ovarian endocrine activity as determined by the increase in uterine weight.
The major structural changes within the ovary as a result of injection of 3 pg FSH-S15 were the production of large antral follicles and increased development of the interstitial tissue. Ultrastructurally, the large follicles appeared to be no different from the large follicles present in ovaries from normal animals. The mean granulosa cell area was not significantly different in treated animals (41-9 ± 2-2 pm2) from that in normal mice (47-3 + 71 pm2), and no differences in the size and distribution of organelles were observed. The thecal cell layers also appeared similar to those in normal animals.
The overall amount of the stromal tissue was increased by injection of 3 pg FSH-S15 and the interstitial cells showed ultrastructural changes, perhaps the most prominent of which was a change in the size of the intracellular lipid droplets. The ovaries of untreated hpg females contain a small number of large lipid droplets, the size distribution of which is shown in Fig. 1 . Treatment with 3 pg FSH-S15 produced a redistribution in the size of these droplets, whilst also increasing their total number; however, the number and size of the droplets was still not the same as that seen in normal animals (Fig. 1) . The effect of injection of 2 pg FSH-S15 on the interstitial cells was similar to that of3pgFSH-S15.
LER 81116 hFSH
The effects upon the ovarian follicle population are shown in Table 3 . Doses of 3 and 6pg increased the number of type 3b follicles and stimulated antral follicle development, but had relatively little effect upon the medium-sized follicles. The increase in the size of the growing follicle population and the number of antral follicles produced was similar to that seen in animals treated with ovine FSH (Tables 1 & 2) . The effects upon uterine weights (Table 3) were similar to those with sheep FSH, with 3 and 6 pg producing a significant increase compared to untreated animals.
NIH-0LH-S24
The effects on the ovarian follicle population of twice daily injections of NIH-oLH-S24 for 5 days are shown in Table 4 . Neither 60 ng nor 2 pg had any significant effect upon the follicle population, and antral follicles were not formed. These doses also had no significant effect upon the uterine weight (Table 4) .
NIH-OFSH-S15 combined with NIH-oFSH-S24
As shown in Table 4 , neither dose of LH in combination with 600 ng FSH had any significant effect upon the follicle population and antral follicles were not formed. When 2 pg FSH-S15 were 1-0* 1-1 1-1** 1-2 3µg 9 37-2 + 11-0+ 5-0 ± 2-8 ± 2-1 ± 1-4 ± 4-0 ± 19-2 + 4-5** 1-6 11 0-7 0-6* 0-5** 1-2** 5-3* 6µg 9 48-1 ± 7-0+ 4-4+ 4-2+ 2-1+ 2-0+ 3-9+ 45-2 ± 5-8** 1-3 10 0-6 0-6* 0-6** 0-6** 5-9*** Compared with untreated hpg females: *P < 0-05; **P < 001; ***P < 0001. given in combination with 60 ng LH-S24 there was a significant increase (P < 001) in the number of type 3b follicles compared with 2 pg FSH alone, but the effect on antral follicle production was no different from that with 2 pg FSH-S15 alone ( Table 2 ). The effects of 2 pg LH-S24 in combi¬ nation with 2 pg FSH-S15 were not significantly different from those of 60 ng LH + 2 pg FSH-S15 in terms of healthy growing follicles, but the higher dose of LH also produced luteinized follicles in 5 out of 9 animals. These are follicles in which the granulosa cells appear to have undergone luteinization, but which still contain the oocyte within an antrum. They have been reported to be formed by a ripe follicle responding to a sub-threshold ovulatory dose of LH or by an immature follicle responding prematurely to an ovulatory dose of LH (Holsinger & Everett, 1970; Peters & McNatty, 1980) .
Neither dose of LH in combination with 600 ng FSH-S 15 had a significant effect on the uterine weight (Table 4) . Addition of 60 ng LH to 2 pg FSH-S 15 caused no further increase in the uterine weight above that produced by 2 pg FSH alone (Tables 2 & 4 ), but addition of 2 pg LH to 2 pg FSH-S15 produced a significantly smaller (P < 0001) increase in uterine weight than that produced by 2 pg FSH alone (Tables 2 & 4) .
Injection of 60 ng LH alone or in combination with 600 ng FSH-S 15 had no significant effect upon the number or size of the interstitial cell lipid droplets, whilst the effect of 60 ng LH in combination with 2 pg FSH-S 15 was similar to that of 2 pg FSH-S 15 alone. A dose of 2 pg LH produced a marked redistribution in the size of the droplets, but their size was still not the same as that seen in normal females. The addition of 600 ng FSH or 2 pg FSH had no significant effect upon the size distribution of droplets produced by injection of 2 pg LH.
Discussion
Hypogonadal mice are deficient in hypothalamic GnRH (Cattanach et al, 1977) as a result of a deletion in the GnRH gene (Mason et al, 1986a) and have an associated reduction in pituitary and plasma gonadotrophin concentrations. Adult animals of both sexes are severely hypogonadal, but the ovaries are capable of apparently normal function when transplanted into a normal endocrine environment (Bamber et al., 1980) or when the genetic defect is corrected (Mason et al, 1986b) .
All three preparations of FSH produced an increase in the number of type 3b follicles, which are the earliest of the growing follicles. This is consistent with our previous observations that a deficiency of gonadotrophins results in a reduction in the size of the population of growing follicles as a result of a reduction in the rate at which non-growing follicles enter the pool of growing follicles (Halpin et al, 1986a, b) . The mechanism of the effect is unclear, but there is evidence that it is due principally to a reduction in the number of follicles lost to atresia rather than to a stimulation of growth per se (Halpin et al., 1986a) . No significant increases in the number of medium-sized follicles were observed with any of the treatments, but given the increase in the initiation of follicle growth and the formation of antral follicles, it is possible that the growth of medium-sized follicles may be stimulated without an observable change in the number of these follicles.
All three preparations of FSH also stimulated antral follicle development and this response showed saturation, at the same dose despite the fact that the reported activity of LER 8/116 is over twice that of NIH-FSH-S13, with NIH-FSH-S15 having an intermediate activity. Moreover, doses of 6 pg and above produced approximately the same number of antral follicles as that found in normal adult females (Halpin et al, 1986b) . A superovulatory response did not occur with these preparations, unlike PMSG which has been shown to stimulate superovulation in hpg females (Ward, 1980) . This may have been due to the relative purity of the FSH preparations used in these studies, since PMSG has a dual FSH/LH like activity (Ben-Or, 1970; Dorfman, 1972) ; however, superovulation was not produced by the combined injection of FSH and LH and therefore this phenomenon may, at least in part, reflect the longer half-life of PMSG (Ben-Or, 1972) .
The observation that FSH stimulated the development of antral follicles is in agreement with the work of Hirshfield & Midgley (1978) Although these studies do not completely eliminate the possibility that LH has a permissive effect, they suggest that, in mice at least, an increase in the plasma LH concentration, on its own, is not sufficient to stimulate antral follicle development, and FSH is also required for this process, as was suggested by Lostroh & Johnson (1966 In normal mice the size of the interstitial compartment increases with increasing age and this has been attributed to the formation of interstitial cells from follicular cells, largely by the trans¬ formation of thecal cells (Peters & Levy, 1966) . They possess LH receptors (Charlton et al, 1982) and resemble typical steroid-secreting cells (Mutta, 1958; Fawcett et al, 1969) . Their lipid droplets may contain precursors for steroidogenesis (Stegner, 1970) and changes in the number of lipid droplets have been correlated with gonadotrophic stimulation and steroidogenesis in several species (Barker, 1951; Rennels, 1951; Guraya & Greenwald, 1964; Nagai et al, 1967 ).
In our studies, both FSH and LH affected the ultrastructure of the ovarian interstitial cells, but the effects of the hormones were different, with LH giving rise to smaller droplets than FSH. FSH stimulation produced cells quite unlike those seen in normal females and its effects must be regarded as supraphysiological, as well as indirect since these cells do not appear to have FSH receptors (Peters & McNatty, 1980; Charlton et al, 1982) . Moreover, the effects of LH injections and combined injections differed from those of FSH alone, suggesting that the actions of FSH on the interstitial cells were not due to the LH contamination. In fact, the interstitial cells in animals treated with FSH closely resembled those in oestrogen-2 treated animals (H. M. Charlton, unpublished observations), suggesting that the effects of FSH upon these cells may be mediated by oestrogen released from granulosa cells. In normal circumstances, this effect may represent a feedback mechanism to control interstitial cell production of androgens.
We therefore conclude that on its own FSH can increase the rate at which non-growing follicles enter the growing pool and that this is the hormone which is responsible for rescuing medium-sized follicles from atresia, thereby allowing the development of antral follicles. Moreover, these antral follicles appear capable of secreting physiologically significant amounts of oestrogen under the influence of FSH in the absence of a significant LH stimulus.
